About Anokion
Anokion is a company based in Ecublens (Switzerland) founded in 2010.. Anokion has raised $112.5 million across 3 funding rounds from investors including Pfizer, Celgene and Novo Holdings. The company has 30 employees as of December 31, 2023. Anokion has completed 1 acquisition, including Kanyos Bio. Anokion offers products and services including SynCeD, ACeD-it, ACeD, and MoveS-it. Anokion operates in a competitive market with competitors including Moderna, BeiGene, Biogen, Incyte and Vir Biotechnology, among others.
- Headquarter Ecublens, Switzerland
- Employees 30 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Anokion Us Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$112.5 M (USD)
in 3 rounds
-
Latest Funding Round
$35 M (USD), Series B
Oct 18, 2022
-
Investors
Pfizer
& 4 more
-
Employee Count
30
as on Dec 31, 2023
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anokion
Anokion offers a comprehensive portfolio of products and services, including SynCeD, ACeD-it, ACeD, and MoveS-it. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for celiac disease treatment via immune tolerance.
Targets celiac disease with antigen-specific interventions.
Focuses on celiac disease immune tolerance therapies.
Develops treatments for multiple sclerosis using tolerance methods.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Anokion
Anokion has successfully raised a total of $112.5M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $35 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $35.0M
-
First Round
First Round
(09 May 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series B - Anokion | Valuation | Pfizer |
|
| Sep, 2019 | Amount | Series B - Anokion | Valuation | Celgene | |
| May, 2014 | Amount | Series A - Anokion | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anokion
Anokion has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Pfizer, Celgene and Novo Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Investments are made in innovative life science companies globally.
|
Founded Year | Domain | Location | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anokion
Anokion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Kanyos Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Antigen-specific immune tolerance technology for two specific autoimmune indications, type-1 diabetes and celiac disease
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Anokion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anokion Comparisons
Competitors of Anokion
Anokion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Biogen, Incyte and Vir Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anokion
Frequently Asked Questions about Anokion
When was Anokion founded?
Anokion was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Where is Anokion located?
Anokion is headquartered in Ecublens, Switzerland. It is registered at Ecublens, Vaud, Switzerland.
Is Anokion a funded company?
Anokion is a funded company, having raised a total of $112.5M across 3 funding rounds to date. The company's 1st funding round was a Series A of $37.5M, raised on May 09, 2014.
How many employees does Anokion have?
As of Dec 31, 2023, the latest employee count at Anokion is 30.
What does Anokion do?
Anokion was founded in 2010 in Ecublens, Switzerland, within the biotechnology sector. Therapeutic proteins are developed using antigen-specific immune tolerance technology to address autoimmune and allergic diseases. The platform is designed to reduce immunogenicity of proteins and enable treatments across various clinical indications. Operations focus on translating this technology to multiple protein-based therapies for immune-related conditions.
Who are the top competitors of Anokion?
Anokion's top competitors include Moderna, BeiGene and ADMA Biologics.
What products or services does Anokion offer?
Anokion offers SynCeD, ACeD-it, ACeD, and MoveS-it.
How many acquisitions has Anokion made?
Anokion has made 1 acquisition, including Kanyos Bio.
Who are Anokion's investors?
Anokion has 5 investors. Key investors include Pfizer, Celgene, Novo Holdings, Novartis Venture Fund, and Versant Ventures.